Medicine & Life Sciences
Off-Label Use
100%
Olanzapine
90%
Risk Assessment
62%
Nausea
41%
Anorexia
30%
Sleep Initiation and Maintenance Disorders
29%
Anxiety
26%
Alprazolam
26%
Neoplasms
24%
Mouth
16%
cabozantinib
15%
palbociclib
14%
Denosumab
13%
Emetics
13%
Letrozole
12%
Lactulose
12%
Oxycodone
12%
Carcinoma, Ductal, Breast
12%
Muscle Fatigue
11%
Cachexia
11%
Antiemetics
11%
gemcitabine
10%
Confusion
10%
Muscle Weakness
9%
Appetite
9%
Palliative Care
9%
Renal Cell Carcinoma
8%
Morphine
8%
Dexamethasone
8%
Cisplatin
8%
Opioid Analgesics
8%
Health Personnel
8%
Vomiting
8%
Weight Loss
7%
Therapeutics
7%
Adenocarcinoma
7%
Sleep
7%
Placebos
6%
Randomized Controlled Trials
6%
Depression
6%
Quality of Life
6%
Drug Therapy
5%
Pain
5%